In these patients, negative symptoms partially mediated the relationship between age of onset and cognitive deficits, which was moderated by serum BDNF and Val66Met polymorphism, since the mediating effect of negative symptoms exhibited a Met allele dose-dependent tendency (36). Here, BDNF is linked to Cognitive impairment.